Posts

How To Quit Smoking With CBD

How To Quit Smoking With CBD

Nov 16, 2023

If you smoke, chances are you’ve thought about quitting or have even tried to at...

Teva Secures $100M Funding to Expedite Schizophrenia Drug Development

Teva Secures $100M Funding to Expedite Schizophrenia Dr...

Nov 16, 2023

Teva has tapped into royalty funding to speed up the development of an antipsych...

New York University Study Finds Prominent Breakthrough for Pain Management; Outperforms Pain Drug

New York University Study Finds Prominent Breakthrough ...

Nov 16, 2023

Researchers at New York University have made an important discovery in the field...

Pfizer’s Cost-Cutting Measures Impact UK’s Sandwich Site, Leading to Job Loss for 500 Employees

Pfizer’s Cost-Cutting Measures Impact UK’s Sandwich Sit...

Nov 16, 2023

Earlier this month, Pfizer, the pharmaceutical giant, extended its cost-cutting ...

Novo Says Weight Loss Alone Isn’t to Thank For Wegovy’s Heart Benefits

Novo Says Weight Loss Alone Isn’t to Thank For Wegovy’s...

Nov 16, 2023

Novo Nordisk unveiled fresh findings at a prominent medical conference, indicati...

Plocabulin by Pharma Mar for Biliary Tumor: Likelihood ...

Nov 16, 2023

Plocabulin is under clinical development by Pharma Mar and currently in Phase I ...

Plocabulin by Pharma Mar for Adenocarcinoma: Likelihood...

Nov 16, 2023

Plocabulin is under clinical development by Pharma Mar and currently in Phase I ...

Plocabulin by Pharma Mar for Peritoneal Cancer: Likelih...

Nov 16, 2023

Plocabulin is under clinical development by Pharma Mar and currently in Phase I ...

Plocabulin by Pharma Mar for Epithelial Ovarian Cancer:...

Nov 16, 2023

Plocabulin is under clinical development by Pharma Mar and currently in Phase I ...

Pembrolizumab by Merck for Sezary Syndrome: Likelihood ...

Nov 16, 2023

Pembrolizumab is under clinical development by Merck and currently in Phase II f...

Pembrolizumab by Merck for Mycosis Fungoides: Likelihoo...

Nov 16, 2023

Pembrolizumab is under clinical development by Merck and currently in Phase II f...

Gedeptin by GeoVax Labs for Nasopharyngeal Cancer: Like...

Nov 16, 2023

Gedeptin is under clinical development by GeoVax Labs and currently in Phase II ...

Rimegepant sulfate ODT by Pfizer for Rhinosinusitis: Li...

Nov 16, 2023

Rimegepant sulfate ODT is under clinical development by Pfizer and currently in ...

ATX-304 by Amplifier TX for Cardiometabolic Disease: Li...

Nov 16, 2023

ATX-304 is under clinical development by Amplifier TX and currently in Phase I f...

Vamorolone by ReveraGen BioPharma for Becker Muscular D...

Nov 16, 2023

Vamorolone is under clinical development by ReveraGen BioPharma and currently in...

University of Kentucky bioengineer designs tools to improve treatment for head and neck cancer

University of Kentucky bioengineer designs tools to imp...

Nov 15, 2023

LEXINGTON, Ky. (Nov. 15, 2023) — One University of Kentucky researcher is workin...